ReGen Therapeutics Plc: Issue of Equity | Company Announcements

Thursday 14 January, 2010

ReGen Therapeutics Plc

Issue of Equity






For immediate release
14 January 2010

                             ReGen Therapeutics Plc

                                Issue of Equity


ReGen  Therapeutics  Plc  ("ReGen"  or  the  "Company"), (AIM:RGT) is pleased to
announce that it has conditionally placed 8,333,333 new ordinary shares at 1.5p
per ordinary share to raise £125,000 before expenses for general working capital
purposes.

The  8,333,333 new ordinary  shares, which  will represent  18.5 per cent of the
enlarged  issued  share  capital  of  the  Company  (in  aggregate  amounting to
45,063,215 ordinary shares on completion of the placing), will rankpari passu in
all respects with the existing ordinary shares in the Company.

The  Board sees this  placing by our  Broker as further  evidence of the growing
confidence in the investment community for ReGen's future.

Application  has been  made to  the London  Stock Exchange  for the new ordinary
shares to be admitted to trading on AIM and admission is expected to commence on
or around Tuesday, 19 January 2010.

For further information, please contact:

Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920

Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396

David Scott/Nick Bealer
Alexander David Securities Limited
Tel: 020 7448 9820

ENDS


[HUG#1373512]

Investegate takes no responsibility for the accuracy of the information within the site.

The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.